Advertisement

Advertisement

CYDY Stock Latest News

Natera, CytoDyn collaborate to advance ctDNA-guided development

The FlyNatera, CytoDyn collaborate to advance ctDNA-guided development

CytoDyn Highlights Encouraging Early Leronlimab Colorectal Cancer Data

PremiumCompany Announcements

CytoDyn Highlights Encouraging Early Leronlimab Colorectal Cancer Data

1M ago

CytoDyn Extends Convertible Debt Maturities, Lowers Interest Costs

PremiumCompany Announcements

CytoDyn Extends Convertible Debt Maturities, Lowers Interest Costs

2M ago

CytoDyn Boosts Liquidity Through Significant Unregistered Equity Sales

PremiumCompany Announcements

CytoDyn Boosts Liquidity Through Significant Unregistered Equity Sales

3M ago

CytoDyn closes $17.5M financing for leronlimab development

PremiumThe Fly

CytoDyn closes $17.5M financing for leronlimab development

3M ago

CytoDyn announces new data on leronlimab’s treatment of mTNBC

PremiumThe FlyCytoDyn announces new data on leronlimab’s treatment of mTNBC

3M ago

CytoDyn announces benefactor committed funding to support EAP

The Fly

CytoDyn announces benefactor committed funding to support EAP

4M ago

CytoDyn releases 2025 December letter to shareholders

The Fly

CytoDyn releases 2025 December letter to shareholders

6M ago

CytoDyn announces findings on PD-L1 survival in triple-negative breast cancer

PremiumThe Fly

CytoDyn announces findings on PD-L1 survival in triple-negative breast cancer

6M ago

CytoDyn Reaches Settlement in Securities Lawsuit

PremiumCompany Announcements

CytoDyn Reaches Settlement in Securities Lawsuit

6M ago

CytoDyn announces resolution of class action lawsuit

PremiumThe Fly

CytoDyn announces resolution of class action lawsuit

6M ago

CytoDyn Approves Share Increase at Annual Meeting

PremiumCompany Announcements

CytoDyn Approves Share Increase at Annual Meeting

6M ago

CytoDyn Secures $30 Million Funding Commitment

PremiumCompany AnnouncementsCytoDyn Secures $30 Million Funding Commitment

7M ago

CytoDyn secures $30M commitment from Yorkville Advisors

The Fly

CytoDyn secures $30M commitment from Yorkville Advisors

7M ago

CytoDyn’s Phase 2 Study: A Potential Breakthrough in mCRC Treatment

Company Announcements

CytoDyn’s Phase 2 Study: A Potential Breakthrough in mCRC Treatment

7M ago

CytoDyn CEO says moving with ‘discipline and urgency’ along ‘well-defined’ path

PremiumThe Fly

CytoDyn CEO says moving with ‘discipline and urgency’ along ‘well-defined’ path

8M ago

CytoDyn to present poster at AACR conference on mTNBC

PremiumThe Fly

CytoDyn to present poster at AACR conference on mTNBC

8M ago

CytoDyn files $100M mixed securities shelf

PremiumThe Fly

CytoDyn files $100M mixed securities shelf

10M ago

CytoDyn announces survival data in patients with mCRC treated with leronlimab

PremiumThe Fly

CytoDyn announces survival data in patients with mCRC treated with leronlimab

11M ago

CytoDyn announces first patient dosed in Phase II oncology trial

PremiumThe FlyCytoDyn announces first patient dosed in Phase II oncology trial

12M ago

CytoDyn announces data on mechanism of action of leronlimab

The Fly

CytoDyn announces data on mechanism of action of leronlimab

1y ago

CytoDyn Appoints Robert Hoffman as New CFO

Company Announcements

CytoDyn Appoints Robert Hoffman as New CFO

1y ago

Trending

S&P 500

―

Dow Jones

―

Nasdaq 100

―

More Trending Stocks >